Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Southwest College of Naturopathic Medicine
This study will assess the safety and efficacy of the use of DMSA (an FDA-approved medication for treating lead poisoning in children) for the off-label treatment of symptoms of autism in children with autism and significant body burden of toxic metals.
Age
3–8
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Phase One
1. Children with autism spectrum disorder
2. Age 3-8 years (up to the day before the ninth birthday).
3. At least a two-month history of taking a multi-vitamin/mineral supplement with at least the RDA of zinc, and continuing to take that during Phase One and Two.
Phase Two:
1. Excretion of high amounts of toxic metals in phase one
2. Normal kidney/liver function, serum transaminases, and Complete Blood Count (CBC) (based on a blood test which will be conducted as part of Phase Two)
3. No changes in medication, supplements, diet, or behavioral interventions during the study
You may not be if
Phase One and Two:
No mercury amalgam dental fillings.
No previous use of DMSA or other prescription chelators (except for 1-time challenges).
No anemia or currently being treated for anemia due to low iron.
